LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Lapatinib | 0.12 | uM | LJP6 | 3 | M23 | 72 | hr | 929 | 3133 | 3228 | 0.9706 | 0.9587 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 1 | G05 | 72 | hr | 929 | 2919 | 3228 | 0.9043 | 0.8656 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 2 | G05 | 72 | hr | 929 | 3081 | 3228 | 0.9544 | 0.9360 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 3 | G05 | 72 | hr | 929 | 3051 | 3228 | 0.9452 | 0.9230 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 1 | J11 | 72 | hr | 929 | 3148 | 3228 | 0.9752 | 0.9652 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 2 | J11 | 72 | hr | 929 | 3087 | 3228 | 0.9563 | 0.9386 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 3 | J11 | 72 | hr | 929 | 3129 | 3228 | 0.9693 | 0.9569 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 929 | 3116 | 3228 | 0.9653 | 0.9513 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 929 | 3185 | 3228 | 0.9867 | 0.9813 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 929 | 3110 | 3228 | 0.9634 | 0.9486 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 1 | C23 | 72 | hr | 929 | 1055 | 3228 | 0.3268 | 0.0547 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 2 | C23 | 72 | hr | 929 | 899 | 3228 | 0.2785 | -0.0132 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 929 | 1097 | 3228 | 0.3398 | 0.0730 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 1 | C23 | 72 | hr | 929 | 950 | 3228 | 0.2943 | 0.0090 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 2 | C23 | 72 | hr | 929 | 912 | 3228 | 0.2825 | -0.0075 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 3 | C23 | 72 | hr | 929 | 962 | 3228 | 0.2980 | 0.0142 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 1 | F05 | 72 | hr | 929 | 2566 | 3228 | 0.7949 | 0.7120 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 2 | F05 | 72 | hr | 929 | 2611 | 3228 | 0.8088 | 0.7316 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 3 | F05 | 72 | hr | 929 | 2748 | 3228 | 0.8513 | 0.7912 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 929 | 2658 | 3228 | 0.8234 | 0.7520 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 929 | 2780 | 3228 | 0.8612 | 0.8051 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 929 | 2682 | 3228 | 0.8308 | 0.7625 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 929 | 3580 | 3228 | 1.1090 | 1.1531 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 2 | N17 | 72 | hr | 929 | 3709 | 3228 | 1.1490 | 1.2092 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 3 | N17 | 72 | hr | 929 | 3733 | 3228 | 1.1564 | 1.2197 |